Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 20Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Lung Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Unilateral Breast Neoplasms 1Triple Negative Breast Neoplasms 1Transsexualism 1Recurrence 1Pancreatic Neoplasms 1Inflammatory Breast Neoplasms 1Gynecomastia 1Chordoma 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1Breast Cancer Female 1Anisomastia 1Amenorrhea 1Adenocarcinoma of Lung 1

Interventions

Therapeutics 2Specimen Handling 2Early Intervention, Educational 2pegfilgrastim 1cediranib 1X-Rays 1Palliative Care 1Neoadjuvant Therapy 1Methods 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Indocyanine Green 1Hypnosis 1High-Energy Shock Waves 1Filgrastim 1Exercise Test 1Educational Status 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Clostridium perfringens epsilon-toxin 1Analgesia 1Accelerometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Inflammatory Breast Neoplasms × Mastectomy, Segmental × Clear all
NCT06131632 2024-01-23

ConSIBreC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Not yet recruiting
300 enrolled
Breast

Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡